Fusion peptide–directed antibodies: Humoral armor against HIV-1 infection
Science Translational Medicine · 17.01.2024 · 16 (730)
DOI: 10.1126/scitranslmed.adl2162 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Translational Medicine, erschienen am 17.01.2024. Verfasst von P J Klasse. Beteiligte Einrichtung: Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Simian Immunodeficiency Virus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Infused neutralizing antibodies to the fusion peptide of the HIV envelope glycoprotein protected macaques from mucosal viral challenge (Pegu et al. ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY 10021, USA.
ORCID-Profile: P J Klasse
Förderung
- NIAID NIH HHS
Zitieren
APA
Klasse, P. J. (2024). Fusion peptide–directed antibodies: Humoral armor against HIV-1 infection. Science Translational Medicine, 16(730). https://doi.org/10.1126/scitranslmed.adl2162
Vancouver
Klasse PJ. Fusion peptide–directed antibodies: Humoral armor against HIV-1 infection. Science Translational Medicine. 2024;16(730). doi:10.1126/scitranslmed.adl2162
BibTeX
@article{Klasse2024,
author = {Klasse, P J},
title = {Fusion peptide–directed antibodies: Humoral armor against HIV-1 infection},
journal = {Science Translational Medicine},
year = {2024},
volume = {16},
number = {730},
doi = {10.1126/scitranslmed.adl2162}
}
EUVIMED